This study is in progress, not accepting new patients
A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCLA UCSD
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Ionis Pharmaceuticals, Inc.
- ID
- NCT05610280
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- About 1478 people participating
- Last Updated